Sanofi, GlaxoSmithKline signs deal with Canada to deliver 72 million doses of potential COVID-19 vaccineMarket Watch • 09/22/20
Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccineGlobeNewsWire • 09/22/20
Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Principia Biopharma Inc.GlobeNewsWire • 09/22/20
Sanofi : Information concerning the total number of voting rights and shares - July 2020GlobeNewsWire • 09/11/20
Sanofi Genzyme continues research to improve the lives of patients with multiple sclerosis, with new data presented at MSVirtual2020PRNewsWire • 09/09/20
Covid Roundup: Coronavirus Vaccine Makers Pledge To Follow Science; Sanofi Eyes PriceInvestors Business Daily • 09/08/20
Nine biopharma CEOs pledge to make safety the main focus in coronavirus vaccine developmentCNBC • 09/08/20
15 High-Yield, Low Volatility Blue-Chips For The Ultimate Crash-Proof Retirement PortfolioSeeking Alpha • 09/07/20
15 High-Yield, Low Volatility Blue-Chips For The Ultimate Sleep Well At Night Retirement PortfolioSeeking Alpha • 09/07/20
Moderna, Pfizer, Johnson & Johnson, And Others To Make Pledge in Response to Coronavirus Vaccine Political PressureThe Motley Fool • 09/05/20
Better Late Than Never: Sanofi and GlaxoSmithKline Start Coronavirus Vaccine Clinical Trial ProgramThe Motley Fool • 09/03/20